StockWatch
·

INDO RAMA SYNTHETICS (INDIA) LTD. Q1 FY27 Results

INDORAMAQ1 FY27 Results
Filing
Result:Steady· Market: UpMargin expansion
MetricValueChangeQ1 FY26
Revenue936.64 Cr28.3%
Total Income940.20 Cr28.1%
Expenditure876.46 Cr30.2%
PBT63.74 Cr20.8%
Net Profit63.74 Cr20.8%
OPM10.84%3.88pp
NPM6.78%2.75pp
EPS2.4420.8%
View full financials

Textile core metric (revenue) fell sharply -28.3% YoY on volume/geopolitical disruption, and PAT growth was entirely margin-driven rather than core-business-led, capping the quality despite genuine EBITDA/NPM expansion.

Q1 FY-2027 RESULTS · INDORAMA

Indo Rama Q1FY27: PAT up 21% YoY to ₹63.7 Cr as margins expand on 28% revenue drop

PAT +20.83% YoY · revenue -28.27% · margins expanding

29 Jul 2026 · 3 min read
Revenue

₹936.64 Cr

-28.27% YoY

PAT (consolidated)

₹63.74 Cr

+20.83% YoY

Net margin

6.78%

+2.8pp YoY

EPS

₹2.44

Indo Rama Synthetics' consolidated Q1 FY27 (quarter ended June 30, 2026) revenue fell sharply to ₹936.6 Cr, down 28.3% YoY from ₹1,305.7 Cr and down 22.1% QoQ from ₹1,201.7 Cr (on a total-income basis the company's own press release cites -28.15%/-22.10%, matching closely). Despite the steep topline drop, consolidated PAT rose 20.8% YoY to ₹63.7 Cr (from ₹52.75 Cr) though it was essentially flat QoQ (-0.6%) against ₹64.13 Cr. Standalone PAT was ₹33.75 Cr on standalone revenue of ₹817.5 Cr. Consolidated is the primary basis, capturing the parent plus four subsidiaries, and standalone tells a materially softer story: standalone PAT rose only 4.5% YoY (₹33.75 Cr vs ₹32.31 Cr) on a steeper 31.0% revenue decline (₹817.5 Cr vs ₹1,184.9 Cr) — the subsidiaries are doing the heavy lifting on profit this quarter.

The scoreboard

Q1 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q1 FY-2027QoQYoY
Revenue₹936.64 Cr-14.6%-28.3%
Expenses₹876.46 Cr-17.4%-30.2%
PAT₹63.74 Cr-0.61%+20.83%
Net margin6.78%+2.8pp+2.8pp
EPS₹2.44+45.2%+20.8%

The expansion is entirely margin-driven. EBITDA margin rose to 11.49% from 7.66% a year ago and 10.08% last quarter (~383bps YoY, ~141bps QoQ), which management attributes to "improved margins, product mix and volatile market sentiments." NPM expanded similarly to 6.78% from 4.03% YoY (5.31% in Q4 FY26). The revenue decline itself is framed by the company as a volume impact tied to "West Asia geo-political issues" rather than a pricing or cost problem — cost of materials and total expenses fell roughly in step with revenue, which is why the margin line still improved. No exceptional items were booked this quarter (FY26's full year carried a ₹2.70 Cr one-off employee-benefit exceptional cost, not present in this comparable quarter), so the YoY PAT growth is on a clean, like-for-like base. Tax expense was nil in both periods, as in prior quarters.

32.9938.644.249.855.4153.2404-2705-1906-1107-0607-2807-29Q1 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹53.24, up 20.7% over the past month of trading.

₹ Cr
019.6939.3959.0813.59Q3 FY25rev ₹1,166 Cr51.07Q4 FY25rev ₹1,198 Cr52.75Q1 FY26rev ₹1,306 Cr24.55Q2 FY26rev ₹1,221 Cr8.78Q3 FY26rev ₹1,182 Cr43.77Q4 FY26rev ₹1,097 Cr
Quarterly consolidated PAT, ₹ Crore

For context: this is the highest quarterly PAT in the last 6 quarters on our records.

No formal analyst consensus estimates or management guidance for this quarter were found in our records or a web search, so vsStreet and vsGuidance are both unknown — this is a small/mid-cap polyester name without dense sell-side coverage, and management gives no formal forward guidance on record. The result was declared alongside unrelated governance actions on the same board date (29 July 2026): reappointment of Chairman & Managing Director Om Prakash Lohia for a further 3 years and independent director Dharmpal Agarwal for a further 5 years, plus reconstitution of the Stakeholders Relationship Committee — none of which bear on the quarter's numbers. Within the quarter itself the company also lost independent director Dhanendra Kumar to death (29 May 2026).

  • W1

    Whether the 11.49% EBITDA margin (vs 7-10% in the prior three quarters) holds in Q2 FY27 or reverts, since management ties the gain to "product mix" and "volatile market sentiments" rather than a structural cost change

  • W2

    Whether the West-Asia-linked volume drag on revenue (-28.3% YoY, -22.1% QoQ) eases or persists into Q2 FY27

  • W3

    Standalone-vs-consolidated PAT growth divergence (4.5% vs 20.8% YoY) — watch whether the subsidiaries' outsized contribution normalizes

Informational and educational content only. Not investment advice.

INDO RAMA SYNTHETICS (INDIA) LTD. (INDORAMA) Q1 FY27 Results — StockWatch